# Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction

> **NCT01372930** · PHASE4 · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Etanercept
- **DRUG:** saline

## Key facts

- **NCT ID:** NCT01372930
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-04
- **Primary completion:** 2014-07
- **Final completion:** —
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2011-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01372930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01372930, "Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01372930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
